LifeTech Scientific Corp
HKEX:1302
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.31
2.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LifeTech Scientific Corp stock under the Base Case scenario is 2.2 HKD. Compared to the current market price of 1.67 HKD, LifeTech Scientific Corp is Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
LifeTech Scientific Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for LifeTech Scientific Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
LifeTech Scientific Corp
Balance Sheet Decomposition
LifeTech Scientific Corp
Current Assets | 2.2B |
Cash & Short-Term Investments | 1.2B |
Receivables | 503.2m |
Other Current Assets | 548.6m |
Non-Current Assets | 2.5B |
Long-Term Investments | 804.1m |
PP&E | 921.5m |
Intangibles | 656.7m |
Other Non-Current Assets | 83m |
Current Liabilities | 770.1m |
Accounts Payable | 710.2m |
Other Current Liabilities | 60m |
Non-Current Liabilities | 556m |
Long-Term Debt | 561.3m |
Other Non-Current Liabilities | -5.3m |
Earnings Waterfall
LifeTech Scientific Corp
Revenue
|
1.3B
CNY
|
Cost of Revenue
|
-274.3m
CNY
|
Gross Profit
|
1B
CNY
|
Operating Expenses
|
-750.9m
CNY
|
Operating Income
|
255.3m
CNY
|
Other Expenses
|
-6.7m
CNY
|
Net Income
|
248.6m
CNY
|
Free Cash Flow Analysis
LifeTech Scientific Corp
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
LifeTech Scientific Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
LifeTech Scientific Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
LifeTech Scientific Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
LifeTech Scientific Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
LifeTech Scientific Corp
According to Wall Street analysts, the average 1-year price target for LifeTech Scientific Corp is 2.69 HKD with a low forecast of 2.67 HKD and a high forecast of 2.77 HKD.
Dividends
Current shareholder yield for LifeTech Scientific Corp is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
Contact
IPO
Employees
Officers
The intrinsic value of one LifeTech Scientific Corp stock under the Base Case scenario is 2.2 HKD.
Compared to the current market price of 1.67 HKD, LifeTech Scientific Corp is Undervalued by 24%.